New research suggests that obese patients in treatment for chronic hepatitis C infection are more likely to achieve better results if the abnormalities associated with excessive fat tissue are corrected first. Obesity is considered a metabolic condition, not merely a matter of being very overweight, according to lead author Michael R. Charlton of the Mayo Clinic and colleagues. In HCV-infected patients, obesity is associated with inflammation and insulin resistance, a prediabetic abnormality of blood sugar. Obese HCV patients may also have steatosis, fatty liver disease; liver scarring; fibrosis progression; and poor response to standard HCV treatments interferon and ribavirin. In addition, HCV patients with obesity-related fatty liver disease are at increased risk for more advanced liver disease. The investigators identified weight loss to reduce fat tissue as a key step to improving response to treatment. Treatment with diabetes drugs like metformin and pioglitazone to raise insulin sensitivity and reduce fat accumulation in the liver might help reverse disease progression, according to the report. Administering higher doses of combination drug therapy for an extended period of time could help offset the decreased drug response. Doses could be determined by body mass index instead of weight, the team wrote. “Treatment strategies that focus on improving underlying metabolic factors associated with poor response to combination therapy are more likely to overcome the low sustained viral response rates observed in obese patients infected with HCV,” the researchers concluded. (Reuters)
These comments are reproduced as written by visitors to this Web site. They have not been edited for content, grammar, or spelling. The viewpoints appearing here are those of the writer, and do not necessarily reflect the opinion or views of advocate.com, The Advocate, or its affiliates.
Be the first to comment on this story.
If you would like to submit a comment for posting, please fill out the form above.
All comments submitted via this form are subject to posting or publication. (To send a private letter to an Advocate editor or writer, please use the e-mail button at the top of the page, or use snail mail.) If you would like your comment considered for publication in The Advocate magazine, please include your full name, your city of residence, and a phone number where you can be reached during business hours so that we can confirm your identity. Your e-mail address and telephone number are strictly confidential and will not be shared or used for any purpose other than to contact you about your comment.
See the Contact page for sending comments for reasons other than responding to Advocate editorial and news stories.
Please note that comments sent by fax or snail mail are unlikely to be posted, although they will be considered for publication along with all letters received via e-mail or via this Web page. Comments that chiefly concern Advocate.com content will be considered for posting only on the Web site. The Advocate reserves the right to edit submitted comments for grammar, spelling, obscenities, or libel; we will, however, do our best to preserve the original comment's style and intent. Comments considered for publication in The Advocate magazine may also be edited for length.